JULIE MONTEIRO-PAI: Open Payments
NPI 1316503808 · COVINGTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 51 payments from 12 companies in 2025. Trend: 2023 $656 · 2024 $643 · 2025 $1,013
Food & beverage: $919Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $294 |
| Janssen Biotech, Inc. | 7 | $198 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $138 |
| Phathom Pharmaceuticals, Inc. | 9 | $111 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| GENZYME CORPORATION | 1 | $37 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: TREMFYA, XIFAXAN, DUPIXENT, VOQUEZNA, RINVOQ, LINZESS, SKYRIZI, ZENPEP.
Industry payments across GA — which companies pay providers there.
